BECTON DICKINSON & CO — fact timeline

BECTON DICKINSON & CO reported second fiscal quarter ending March 31, 2026 results: revenue $4,714, EPS $(0.13) and $2.90. Guidance raised.

“Fiscal 2026 Operating Results Three Months Ended March 31, Reported Change Foreign Currency Neutral Change 1 (Millions of dollars, except per share amounts) 2026 2025 Revenues $ 4,714 $ 4,480 5.2 % 2.6 % Reported Diluted Earnings per Share $ (0.13) $ 0.55 (123.6) % (130.9) % Adjusted Diluted Earnings per Share 1 $ 2.90 $ 2.79 3.9 % 1.1 % 1 Represents a non-GAAP”

Vitor Roque was appointed as Executive Vice President and Chief Financial Officer at BECTON DICKINSON & CO.

“Effective May 7, 2026 (the “Effective Date”), the Company’s Board of Directors (the “Board”) approved the appointment of Mr. Roque as the Company’s Executive Vice President and Chief Financial Officer.”

BECTON DICKINSON & CO: Amended and restated By-laws to update advance notice provision for contested elections and make technical revisions (effective 2026-04-28).

“On April 28, 2026, the Board of Directors of Becton, Dickinson and Company (the “Company”) approved the amendment and restatement of the Company’s By-laws (the “By-laws”). The amendments to the By-laws: (i) update in the advance notice provision the time period to determine the existence of a contested election and (ii) make certain other technical, conforming and clarifying revisions.”

BECTON DICKINSON & CO entered into Transition Services Agreement with Waters and SpinCo.

“On the Closing Date, in connection with the consummation of the Transactions and in accordance with the Merger Agreement and the Separation Agreement, the Company, Waters and SpinCo entered into the following additional agreements: Tax Matters Agreement The Company, Waters and SpinCo entered into a Tax Matters Agreement (the “Tax Matters Agreement”), which governs the parties’ respective rights, responsibilities and obligations with respect to taxes of the Company, SpinCo and their respective subsidiaries (including taxes arising in the ordinary course of business and taxes, if any, incurred as a result of any failure of the Separation or the Distribution to qualify for their intended tax treatment), as well as tax benefits and attributes of, the preparation and filing of tax returns for, the control of audits and other tax proceedings related to, and assistance and cooperation in respec”

BECTON DICKINSON & CO entered into Intellectual Property Matters Agreement with Waters and SpinCo.

“the Company, Waters and SpinCo entered into an Intellectual Property Matters Agreement (the “Intellectual Property Matters Agreement”)”

BECTON DICKINSON & CO entered into Tax Matters Agreement with Waters and SpinCo.

“On the Closing Date, in connection with the consummation of the Transactions and in accordance with the Merger Agreement and the Separation Agreement, the Company, Waters and SpinCo entered into the following additional agreements: Tax Matters Agreement The Company, Waters and SpinCo entered into a Tax Matters Agreement (the “Tax Matters Agreement”), which governs the parties’ respective rights, responsibilities and obligations with respect to taxes of the Company, SpinCo and their respective subsidiaries (including taxes arising in the ordinary course of business and taxes, if any, incurred as a result of any failure of the Separation or the Distribution to qualify for their intended tax treatment), as well as tax benefits and attributes of, the preparation and filing of tax returns for, the control of audits and other tax proceedings related to, and assistance and cooperation in respec”

BECTON DICKINSON & CO: Filed Certificate of Designation of Series D Junior Participating Redeemable Preferred Stock (effective 2026-01-30).

“On January 30, 2026, the Company filed with the Secretary of State of the State of New Jersey a Certificate of Designation (the “Certificate of Designation”) of Series D Junior Participating Redeemable Preferred Stock ("Series D Preferred Stock").”

BECTON DICKINSON & CO: Amended Article II, Section 2.D. to update procedural and disclosure requirements for advance notice of nominations and other business at annual meetings, including revisions for Rule 14a-19, defined terms, order of business, and appointment of officers (effective 2025-04-29).

“On April 29, 2025, the Board of Directors of Becton, Dickinson and Company (the “Company”) amended Article II, Section 2.D. of the By-laws (the “By-laws”) of the Company to update certain procedural and disclosure requirements relating to the advance notice of nominations and other business at an annual meeting of shareholders.”

Gregory J. Hayes was elected as Director at BECTON DICKINSON & CO.

“Effective March 26, 2025, Gregory J. Hayes was elected to the Board of Directors (the “Board”) of Becton, Dickinson and Company (“BD”).”

Pamela L. Spikner was appointed as Senior Vice President, Chief Accounting Officer and Controller at BECTON DICKINSON & CO.

“On January 9, 2025, the Board of Directors (the “Board”) of Becton, Dickinson and Company (the “Company”) appointed Pamela L. Spikner as Senior Vice President, Chief Accounting Officer and Controller, effective January 20, 2025.”

Christopher DelOrefice was appointed as interim principal accounting officer at BECTON DICKINSON & CO.

“Christopher DelOrefice, Executive Vice President and Chief Financial Officer, will assume the responsibilities of principal accounting officer on an interim basis.”

Thomas Spoerel was appointed as Senior Vice President, CFO Regions at BECTON DICKINSON & CO.

“Thomas Spoerel will serve as the Senior Vice President, CFO Regions along with finance leadership for the finance integration of the recently announced agreement for Becton Dickinson to acquire the Edwards Life Sciences’ Critical Care product group.”

BECTON DICKINSON & CO updated its its second quarter of fiscal 2024, which ended March 31, 2024 guidance (raised).

“On May 2, 2024, Becton, Dickinson and Company (“BD”) issued a press release announcing its financial results for its second fiscal quarter ending March 31, 2024.”

David Hickey departed as Executive Vice President and President of the Life Sciences segment at BECTON DICKINSON & CO.

“On February 22, 2024, David Hickey, Executive Vice President and President of the Life Sciences segment of Becton, Dickinson and Company ("BD"), informed BD of his intention to retire, effective July 1, 2024.”

BECTON DICKINSON & CO incurred senior notes of $550,000,000 with public at 5.110% maturing February 8, 2034.

“On February 8, 2024, BD issued (i) $625,000,000 aggregate principal amount of its 4.874% Notes due February 8, 2029 (the “2029 Notes”) and (ii) $550,000,000 aggregate principal amount of its 5.110% Notes due February 8, 2034 (the “2034 Notes” and, together with the 2029 Notes, the “USD Notes”) in an underwritten public offering pursuant to the Indenture.”

BECTON DICKINSON & CO incurred senior notes of $625,000,000 with public at 4.874% maturing February 8, 2029.

“On February 8, 2024, BD issued (i) $625,000,000 aggregate principal amount of its 4.874% Notes due February 8, 2029 (the “2029 Notes”) and (ii) $550,000,000 aggregate principal amount of its 5.110% Notes due February 8, 2034 (the “2034 Notes” and, together with the 2029 Notes, the “USD Notes”) in an underwritten public offering pursuant to the Indenture.”

BECTON DICKINSON & CO incurred senior notes of €750,000,000 with public at 3.519% maturing February 8, 2031.

“On February 8, 2024, Becton, Dickinson and Company (“BD”) issued €750,000,000 aggregate principal amount of its 3.519% Notes due February 8, 2031 (the “Euro Notes”) in an underwritten public offering pursuant to the indenture, dated March 1, 1997, between BD and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Indenture”).”

BECTON DICKINSON & CO shareholders approved Advisory vote on executive compensation at the 2024-01-23 meeting.

“Proposal No. 3 : The shareholders approved, on an advisory, non-binding basis, the compensation of BD’s named executive officers by the votes set forth in the table below.”

BECTON DICKINSON & CO shareholders approved Ratification of Ernst & Young as independent registered public accounting firm for fiscal year 2024 at the 2024-01-23 meeting.

“Proposal No. 2 : The appointment of Ernst & Young as BD’s independent registered public accounting firm for fiscal year 2024 was ratified by the shareholders by the votes set forth in the table below.”

BECTON DICKINSON & CO shareholders approved Election of Directors at the 2024-01-23 meeting.

“Proposal No. 1 : All of the Board of Directors’ nominees for director were elected to serve for a term of one year and until their respective successors are elected and qualified, by the votes set forth in the table below.”

BECTON DICKINSON & CO reported full year of fiscal 2023, which ended September 30, 2023 results: revenue $19.4 billion. Guidance initiated.

“grew 7.3% as reported, 6.3% currency-neutral or 7.0% organic • Q4 GAAP and adjusted diluted EPS from continuing operations of $0.53 and $3.42, respectively • FY23 revenue of $19.4 billion increased 2.7% as reported and 4.5% on a currency-neutral basis • FY23 revenue from base business grew 5.1% as reported, 7.0% currency-neutral or 5.8% organic • FY23 GAAP and”

BECTON DICKINSON & CO reported fourth fiscal quarter ending September 30, 2023 results: revenue $5,087.

“Fiscal 2023 Operating Results Three Months Ended September 30, Change Foreign Currency Neutral Change 1 (Millions of dollars, except per share amounts) 2023 2022 Revenues $ 5,087 $ 4,761 6.8 % 5.9 % Base Revenues 1 $ 5,070 $ 4,724 7.3 % 6.3 % Base Organic Revenue Growth 1 7.0 % Reported Diluted Earnings per Share from Continuing Operations $ 0.53 $ 0.92”

BECTON DICKINSON & CO: Amended Article II, Section 2.D. of By-laws to update advance notice requirements for shareholder nominations and other business at annual meetings, including enhanced disclosure, ownership maintenance, and proxy card color restrictions, with conforming and clarifying revisions (effective 2023-09-19).

“On September 19, 2023, the Board of Directors of Becton, Dickinson and Company (the “Company”) amended Article II, Section 2.D. of the By-laws (the “By-laws”) of the Company to update certain procedural and disclosure requirements relating to the advance notice of nominations and other business at an annual meeting of shareholders.”

BECTON DICKINSON & CO reported financial results for third quarter of fiscal 2023, which ended June 30, 2023.

“On August 3, 2023, Becton, Dickinson and Company (“BD”) issued a press release announcing its financial results for its third fiscal quarter ending June 30, 2023.”

Joanne Waldstreicher was elected as Director at BECTON DICKINSON & CO.

“On July 24, 2023, Dr. Joanne Waldstreicher was elected to the Board of Directors of Becton, Dickinson and Company.”

BECTON DICKINSON & CO reported second quarter of fiscal 2023 results: revenue $4.8 billion, EPS $1.53. Guidance raised.

“BD Reports Second Quarter Fiscal 2023 Financial Results BD 2025 Strategic Investments Driving Growth and Advancing Innovation; Company Raises Mid-point of Revenue and Adjusted EPS Guidance Ranges • Revenue of $4.8 billion increased 1.5% as reported and 4.1% on a currency-neutral basis • Revenue from base business (which excludes COVID-only diagnostic testing) grew 6.0% as reported, 8.7% currency-neutral • GAAP and adjusted diluted EPS from continuing operations of $1.53 and $2.86, respectively • Company raises full-year base revenue guidance, enabling additional investments in growth and innovation while absorbing lower COVID-only diagnostic testing revenue and incremental FX impacts”

BECTON DICKINSON & CO entered into dealer agreement, issue and paying agency agreement and deed of covenant valued at $2,750,000,000 (effective 2023-03-09).

“On March 9, 2023, the Company entered into a dealer agreement, issue and paying agency agreement and deed of covenant pursuant to which it established a multicurrency euro commercial paper program”

BECTON DICKINSON & CO amended Amendment valued at $2,750,000,000 (effective 2023-03-09).

“On March 9, 2023, the Company entered into an omnibus amendment (the “ Amendment ”) with respect to its U.S. commercial paper program”

BECTON DICKINSON & CO incurred senior notes of € 800,000,000 aggregate principal amount with The Bank of New York Mellon Trust Company, N.A. at 3.553 % maturing 3.553 % Notes due September 13, 20 29.

“issued € 800,000,000 aggregate principal amount of its 3.553 % Notes due September 13, 20 29”

BECTON DICKINSON & CO incurred senior notes of $800,000,000 aggregate principal amount with The Bank of New York Mellon Trust Company, N.A. at 4.693% maturing 4.693% Notes due February 13, 2028.

“On February 13 , 2023, BD issued $800,000,000 aggregate principal amount of 4.693% Notes due February 13, 2028”

BECTON DICKINSON & CO reported the first quarter of fiscal 2023 ended December 31, 2022 results: revenue $4.6 billion, EPS $1.70. Guidance raised.

“BD Reports First Quarter Fiscal 2023 Financial Results Execution of BD 2025 Strategy Delivering Consistent and Durable Performance • Revenue of $4.6 billion decreased 2.8% as reported and increased 1.7% on a currency-neutral basis • Revenue from base business (which excludes COVID-only diagnostic testing) grew 0.4% as reported, 5.2% currency-neutral • GAAP and adjusted diluted EPS from continuing operations of $1.70 and $2.98, respectively • Company raises full-year revenue and adjusted EPS guidance”

BECTON DICKINSON & CO shareholders approved Shareholder proposal requiring prior shareholder approval of certain termination payments at the 2023-01-24 meeting.

“Proposal No. 6 : The shareholder proposal to require prior shareholder approval of certain termination payments passed by the votes set forth in the table below.”

BECTON DICKINSON & CO shareholders approved Approval of amendments to BD's 2004 Employee and Directors Equity Plan at the 2023-01-24 meeting.

“Proposal No. 5 : The shareholders approved amendments to BD's 2004 Employee and Directors Equity Plan by the votes set forth in the table below.”

BECTON DICKINSON & CO shareholders approved Advisory vote on frequency of executive compensation votes at the 2023-01-24 meeting.

“Proposal No. 4 : The shareholders approved, on an advisory, non-binding basis, annual advisory votes on named executive officer compensation by the votes set forth in the table below.”

BECTON DICKINSON & CO shareholders approved Advisory vote on executive compensation at the 2023-01-24 meeting.

“Proposal No. 3 : The shareholders approved, on an advisory, non-binding basis, the compensation of BD’s named executive officers by the votes set forth in the table below.”

BECTON DICKINSON & CO shareholders approved Ratification of appointment of Ernst & Young as BD's independent registered public accounting firm for fiscal year 2023 at the 2023-01-24 meeting.

“Proposal No. 2 : The appointment of Ernst & Young as BD’s independent registered public accounting firm for fiscal year 2023 was ratified by the shareholders by the votes set forth in the table below.”

BECTON DICKINSON & CO shareholders approved Election of directors at the 2023-01-24 meeting.

“Proposal No. 1 : All of the Board of Directors’ nominees for director were elected to serve for a term of one year and until their respective successors are elected and qualified, by the votes set forth in the table below.”

BECTON DICKINSON & CO amended revolving credit of $2.75 billion with Citibank, N.A. maturing September, 2026.

“The Credit Agreement is a senior unsecured revolving credit facility that provides the Company with $2.75 billion of financing”

BECTON DICKINSON & CO amended Credit Agreement with Citibank, N.A. and the lenders named therein valued at $2.75 billion (effective 2023-01-25).

“On January 25, 2023, Becton, Dickinson and Company (the “Company”) and Becton Dickinson Euro Finance S.à r.l., a private limited liability company ( société à responsabilite limitée ) organized and existing under the laws of the Grand Duchy of Luxembourg (“BD Euro Finance”) entered into that certain second amended and restated credit agreement (the “Credit Agreement”) with Citibank, N.A. (“Citibank”) as administrative agent, and the lenders named in the Credit Agreement.”

Samrat S. Khichi resigned as Executive Vice President, Corporate Development, Public Policy, Regulatory Affairs and General Counsel at BECTON DICKINSON & CO.

“On December 30, 2022, Samrat S. Khichi, Executive Vice President, Corporate Development, Public Policy, Regulatory Affairs and General Counsel, informed BD of his intent to depart BD for a new opportunity, effective February 3, 2023.”

BECTON DICKINSON & CO reported fiscal year ended September 30, 2022 results: revenue $18.9 billion, EPS $5.38 and $11.35. Guidance initiated.

“• FY22 revenue from continuing operations of $18.9 billion decreased 1.4% as reported and increased 0.9% on a currency-neutral basis • FY22 revenue performance driven by base revenue growth of 6.9% as reported, 9.4% currency-neutral • FY22 GAAP and adjusted diluted EPS from continuing operations of $5.38 and $11.35, respectively”

BECTON DICKINSON & CO reported the fourth fiscal quarter ending September 30, 2022 results: revenue $4.8 billion, EPS $0.92 and $2.75. Guidance initiated.

“• Q4 revenue from continuing operations of $4.8 billion decreased 1.8% as reported and increased 2.3% on a currency-neutral basis • Q4 revenue performance driven by base revenue growth of 4.2% as reported, 8.6% currency-neutral • Q4 GAAP and adjusted diluted EPS from continuing operations of $0.92 and $2.75, respectively”

Simon Campion departed as Executive Vice President and President, Medical Segment at BECTON DICKINSON & CO.

“Simon Campion informed BD that he will depart BD on September 9, 2022 for an executive role in the health care industry.”

Richard Byrd was named as Executive Vice President and President, Interventional Segment at BECTON DICKINSON & CO.

“Richard Byrd has been named BD's Executive Vice President and President, Interventional Segment”

Michael Garrison was named as Executive Vice President and President, Medical Segment at BECTON DICKINSON & CO.

“Michael Garrison has been named BD's Executive Vice President and President, Medical Segment”

David Melcher resigned as director at BECTON DICKINSON & CO.

“each of Claire Pomeroy, MD and David F. Melcher has resigned as directors of BD, in each case effective as of April 1, 2022, in connection with the completion of the Separation and the Distribution and their appointment to the board of directors of embecta.”

Claire Pomeroy resigned as director at BECTON DICKINSON & CO.

“each of Claire Pomeroy, MD and David F. Melcher has resigned as directors of BD, in each case effective as of April 1, 2022, in connection with the completion of the Separation and the Distribution and their appointment to the board of directors of embecta.”

Alberto Mas departed as Executive Vice President and President of the Medical segment at BECTON DICKINSON & CO.

“On March 28, 2022, Alberto Mas, Executive Vice President and President of the Medical segment of BD informed BD of his intention to retire, effective at the end of BD’s fiscal year on September 30, 2022.”

William M. Brown was elected as Director at BECTON DICKINSON & CO.

“On February 28, 2022, William M. Brown was elected to the Board of Directors of Becton, Dickinson and Company (“BD”).”

Carrie L. Byington was elected as Director at BECTON DICKINSON & CO.

“On October 21, 2021, Carrie L. Byington, M.D. was elected to the Board of Directors of Becton, Dickinson and Company (“BD”).”